ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
-10.45%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(-53%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-79.88%
Top 10 Holdings %
Top 10 Hldgs %
67.63%
Holding
31
New
1
Increased
3
Reduced
16
Closed
10
Top Buys
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$5.95M |
| 2 |
Guardant Health
GH
|
$3.64M |
| 3 |
Rapid Micro Biosystems
RPID
|
$1.78M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$1.68M |
Top Sells
| 1 |
Natera
NTRA
|
$25M |
| 2 |
Repligen
RGEN
|
$18.5M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$12.5M |
| 4 |
Sarepta Therapeutics
SRPT
|
$10.8M |
| 5 |
IDEAYA Biosciences
IDYA
|
$10.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Lantheus
LNTH
$3.73B
| $15.8M | 11.68% | 285,000 -45,000 | -14% | -$2.49M |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $10.9M | 8.11% | 650,000 +100,000 | +18% | +$1.68M |
|
|
3
Guardant Health
GH
$8.41B
| $10.6M | 7.86% | 160,000 +55,000 | +52% | +$3.64M |
|
4
Arvinas
ARVN
$568M
| $10.1M | 7.48% | 150,000 -80,000 | -35% | -$5.38M |
|
5
Cogent Biosciences
COGT
$1.69B
| $9.81M | 7.27% | 1,309,430 -192,161 | -13% | -$1.44M |
|
6
Viridian Therapeutics
VRDN
$1.5B
| $9.17M | 6.8% | 496,012 -108,762 | -18% | -$2.01M |
|
7
Fate Therapeutics
FATE
$120M
| $7.04M | 5.22% | 181,500 -88,500 | -33% | -$3.43M |
|
8
Nuvation Bio
NUVB
$1.02B
| $5.98M | 4.43% | 1,137,152 -60,000 | -5% | -$316K |
|
|
CERE
9
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.95M | 4.41% | +170,000 | New | +$5.95M |
|
|
SLGC
10
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $5.9M | 4.37% | 735,000 -65,000 | -8% | -$521K |
|
|
ISO
11
DELISTED
IsoPlexis Corporation Common Stock
ISO
| $5.66M | 4.2% | 1,650,118 -120,000 | -7% | -$412K |
|
|
12
Rapid Micro Biosystems
RPID
$107M
| $4.75M | 3.52% | 699,664 +261,704 | +60% | +$1.78M |
|
13
Nautilus Biotechnolgy
NAUT
$85.9M
| $4.69M | 3.48% | 1,080,566 -144,494 | -12% | -$627K |
|
14
Intellia Therapeutics
NTLA
$1.22B
| $4.36M | 3.23% | 60,000 -5,000 | -8% | -$363K |
|
|
SYRS
15
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $4M | 2.97% | 3,364,895 -175,000 | -5% | -$208K |
|
16
Gossamer Bio
GOSS
$562M
| $3.91M | 2.9% | 450,000 -25,000 | -5% | -$217K |
|
|
JNCE
17
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.74M | 2.77% | 550,000 -25,000 | -4% | -$170K |
|
18
Stoke Therapeutics
STOK
$1.08B
| $3.68M | 2.73% | 175,000 -10,000 | -5% | -$211K |
|
19
Sight Sciences
SGHT
$213M
| $3.64M | 2.7% | 314,804 -27,500 | -8% | -$318K |
|
|
MDVL
20
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $2.84M | 2.1% | 2,920,780 | – | – |
|
|
VERV
21
DELISTED
Verve Therapeutics
VERV
| $2.4M | 1.78% | 105,360 -5,000 | -5% | -$114K |
|
|
CYT
22
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| – | – | -319,538 | Closed | -$3.63M |
|
|
NSTG
23
DELISTED
NanoString Technologies, Inc.
NSTG
| – | – | -185,000 | Closed | -$7.81M |
|
|
MRTX
24
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – | -85,000 | Closed | -$12.5M |
|
|
25
IDEAYA Biosciences
IDYA
$2.15B
| – | – | -430,000 | Closed | -$10.2M |
|